Milacemide, a glycinamide derivative, is an orally active MAO-B inhibitor with anticonvulsant activity. Milacemide reduces the levels of dihydroxyphenylacetic acid and homovanilic acid, but increases the levels of dopamine and serotonin in the caudate nucleus. Milacemide is promising for research of Alzheimers disease[1][2].
Molekulargewicht:
144.21
Reinheit:
98.04
CAS Nummer:
[76990-56-2]
Formel:
C7H16N2O
Target-Kategorie:
Monoamine Oxidase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
